Hua Medicine (Shanghai) Ltd. reported consolidated earnings results for the year ended December 31, 2019. For the year, the company reported loss and total comprehensive expense for the year attributable to owners of the company of RMB 425.3 million or RMB 0.45 per basic and diluted share compared to RMB 3,602.7 million or RMB 10.07 per basic and diluted share a year ago.